ORIGINAL RESEARCH article

Front. Oncol.

Sec. Molecular and Cellular Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1529657

This article is part of the Research TopicRNA Methylation and Demethylation in Tumorigenesis and as Therapeutic TargetsView all 5 articles

METTL3-mediated SNHG1 m 6 A modification promotes proliferation and migration by transcriptional regulation of WDR74 in osteosarcoma

Provisionally accepted
Guanzhen  QiuGuanzhen Qiu1Yuxin  BaoYuxin Bao1Yuanzhuang  ZhangYuanzhuang Zhang1Yeqiu  XuYeqiu Xu1Tianhua  QiaoTianhua Qiao1Chenghao  LiChenghao Li1Hanjie  ZhaiHanjie Zhai1Zhenjun  ChenZhenjun Chen1Fu  RenFu Ren2Yong  WangYong Wang1*
  • 1Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning Province, China
  • 2Shenyang Medical College, Shenyang, Liaoning Province, China

The final, formatted version of the article will be published soon.

RNA methyltransferase-like 3 (METTL3) catalyzes N6-methyladenosine (m6A) modification, broadly affecting the metabolism of coding and noncoding RNAs (ncRNAs). However, its role in small nucleolar RNA host gene 1 (SNHG1)-mediated proliferation and migration in osteosarcoma (OS) remains unclear. In this study, we found that METTL3 was upregulated in OS tissues and cell lines, promoting OS cell proliferation and migration. Mechanistically, METTL3, with the assistance of RNA binding motif protein 15 (RBM15), enhanced m6A modification and stabilized SNHG1. SNHG1, in turn, promoted OS progression by activating its neighboring gene WD repeat domain 74 (WDR74) through EWS RNA binding protein 1 (EWSR1) recruitment. These findings reveal that METTL3-mediated m6A modification stabilizes SNHG1, which transcriptionally activates WDR74 and facilitates OS progression.

Keywords: METTL3, N6-Methyladenosine, SNHG1, WDR74, Osteosarcoma, proliferation/metastasis

Received: 17 Nov 2024; Accepted: 28 Apr 2025.

Copyright: © 2025 Qiu, Bao, Zhang, Xu, Qiao, Li, Zhai, Chen, Ren and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yong Wang, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.